Algalin, commonly referred to as algal oil, is derived from microalgae and is a rich source of omega-3 fatty acids, particularly docosahexaenoic acid (DHA) and sometimes eicosapentaenoic acid (EPA). The use of algal oil to lower high triglycerides has a scientific basis, as omega-3 fatty acids have been extensively studied for their lipid-lowering effects. Multiple randomized controlled trials and meta-analyses have demonstrated that supplementation with omega-3 fatty acids can lead to significant reductions in serum triglyceride levels, especially in individuals with hypertriglyceridemia. While much of the research has traditionally focused on fish oil sources, more recent studies have found that algal oil, as a plant-based alternative, is similarly effective in reducing triglycerides due to its comparable DHA and EPA content.

The American Heart Association recognizes omega-3 supplementation (including algal oil as a source of these fatty acids) as an effective adjunct therapy for lowering triglycerides. Algal oil is particularly valued in vegetarian and vegan populations who wish to avoid animal-derived products. The quality and quantity of omega-3s in algal oil are considered sufficient to exert a clinically meaningful effect on blood triglyceride levels, especially when used in appropriate dosages (typically 2–4 grams per day of EPA/DHA combined).

In summary, there is robust scientific evidence supporting the use of algal oil (Algalin) for managing elevated triglyceride levels, and it has been formally recognized by clinical guidelines as a valid non-pharmaceutical intervention for this purpose.